Skip to content

ABBV

AbbVie Inc.

Income statement

Income statement
Line, in USDLast 12 months202520242023202220212020201920182017201620152014201320122011
Revenue66.0B61.2B56.3B54.3B58.1B56.2B45.8B33.3B32.8B28.2B25.6B22.9B20.0B18.8B18.4B17.4B
Cost of revenue
17.3B18.2B16.9B20.4B17.4B17.4B15.4B7.4B7.7B7.0B5.8B4.5B4.4B4.6B4.5B4.6B
Gross profit48.7B43.0B39.4B33.9B40.6B38.8B30.4B25.8B25.0B21.2B19.8B18.4B15.5B14.2B13.9B12.8B
10.0B9.1B12.8B7.7B6.5B6.9B6.4B6.4B10.3B5.0B4.4B4.3B3.3B2.9B2.8B2.6B
15.2B14.0B14.8B12.9B15.3B12.3B11.3B6.9B7.4B6.3B5.9B6.4B7.7B5.4B5.0B5.9B
Other operating expenses
2.28B4.78B2.75B0.60B0.75B1.56B1.38B—0.92B0.33B0.20B0.15B1.10B0.34B0.29B0.67B
Operating income21.2B15.1B9.1B12.8B18.1B17.9B11.4B13.0B6.4B9.5B9.3B7.5B3.4B5.7B5.8B3.6B
Non-operating income
−8.42B−8.48B−5.42B−6.51B−4.64B−4.94B−7.97B−4.56B−1.19B−1.82B−1.46B−0.89B−1.04B−0.33B−92M48M
Pretax income12.8B6.6B3.7B6.3B13.5B13.0B3.4B8.4B5.2B7.7B7.9B6.6B2.4B5.3B5.7B3.7B
Taxes
2.47B2.37B−0.56B1.39B1.64B1.45B−1.22B0.54B−0.49B2.42B1.93B1.50B0.60B1.20B0.45B0.24B
Net income10.3B4.2B4.3B4.9B11.8B11.5B4.6B7.9B5.7B5.3B6.0B5.1B1.8B4.1B5.3B3.4B
Diluted EPS5.812.362.392.726.636.452.725.283.663.303.633.131.102.563.352.18
Diluted shares—1.77B1.77B1.77B1.78B1.78B1.67B1.48B1.55B1.60B1.63B1.64B1.61B1.60B1.58B1.58B
Revenue growth—+8.6%+3.7%−6.4%+3.3%+22.7%+37.7%+1.6%+16.1%+10.1%+12.2%+14.5%+6.2%+2.2%+5.4%—
Gross margin73.7%70.2%70.0%62.4%70.0%69.0%66.4%77.6%76.4%75.0%77.3%80.3%77.8%75.6%75.5%73.4%
Operating margin32.2%24.6%16.2%23.5%31.2%31.9%24.8%39.0%19.5%33.8%36.4%33.0%17.1%30.1%31.6%20.8%
Net margin15.7%6.9%7.6%9.0%20.4%20.5%10.1%23.7%17.4%18.8%23.2%22.5%8.9%22.0%28.7%19.7%